Clinical Study
Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
Table 2
Comparison between patients with CKD with and without LVH.
| | LVH () | No LVH () | P value |
| Age (years) | | | 0.652 | Male sex | 75% () | 71% () | 0.54 | DM nephropathy | 67% () | 58% () | 0.34 | eGFR (mL/min/1.73 m2) | | | 0.044 | LVMI | 87.9 (84.3–95.1) | 79.6 (73.2–83.8) | 0.045 | Systolic BP (mmHg) | | | 0.002 | Phosphate (mmol/L) | | | 0.21 | Vitamin D (ng/mL) | 13 (5–20) | 14 (4–22) | 0.94 | FGF-23 (RU/mL) | 283.4 (166.4–414.8) | 118.4 (61.5–295) | 0.008 | PTH (pg/mL) | 14.5 (6.7–21.6) | 13.1 (5.9–19.6) | 0.25 | Calcium (mmol/L) | | | 0.9 | Ur PCR (mg/mmol) | 82.5 (19.8–218) | 67.4 (12.5–196) | 0.004 |
|
|